NEW YORK--(BUSINESS WIRE)--#CX--eClerx Services Ltd (ECLERX.NS), a leading productized services company, today announced that it has been named a Major…
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…